Company Overview and News
SHENZHEN, CHINA / ACCESSWIRE / July 10, 2018 / Xunlei Limited (NASDAQ: XNET) and its cloud computing subsidiary Onething Technologies today announced the winners of the inaugural Xunlei Blockchain Applications Global Challenge. This Challenge is aimed to seek the best talent and projects in the blockchain space to solve the real-world issues in China and all over the world.
SHENZHEN, China, July 06, 2018 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq:XNET), a leading cloud-based bandwidth acceleration technology company in China, announced today that it has launched the ThunderChain File System (TCFS) and three TRC Smart Contract Standards to support the development of blockchain applications. The Company also revealed the winners of Xunlei Blockchain Applications Global Challenge final tournament held in Shenzhen.
SHENZHEN, China, May 22, 2018 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq:XNET), a leading cloud-based bandwidth acceleration technology company in China, announced today that the Company’s cloud computing business model for sharing economy was cited by the 2018 White Paper on China’s Blockchain Industry as an endeavor to lower bandwidth cost through innovation, improve internet speed, save energy and reduce carbon dioxide emission.
SHENZHEN, China, May 18, 2018 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei”) (Nasdaq:XNET), an industry leading cloud-based bandwidth acceleration technology company in China, announced today that Mr. Peng Huang will resign from his role as the Company’s Chief Operating Officer for personal reasons. The resignation will be effective on May 31, 2018. Following his resignation, Mr. Huang will continue to support the Company and serve as its strategy consultant.
SHENZHEN, China, May 17, 2018 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq:XNET), a leading cloud-based acceleration technology company in China, today announced that it has launched StellarCloud and ThunderChain Open Platform to build a blockchain ecosystem in a product introduction ceremony held in Beijing on May 16, 2018. The StellarCloud is a shared cloud computing platform which will expand Xunlei’s existing Content Delivery Network (CDN) services to Infrastructure as a Service (IaaS).
Good morning and thank you for standing by for Xunlei's First Quarter 2018 Earnings Conference Call. At this time, all participants are in listen-only mode. After management's presentation, there will be a question-and-answer session. Today's conference call is being recorded.
SHENZHEN, China, May 15, 2018 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq:XNET), a leading cloud-based acceleration technology company in China, today announced its unaudited financial results for the first quarter ended March 31, 2018.
SHENZHEN, China, May 08, 2018 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq:XNET), a leading cloud-based acceleration technology company in China, announced today that it plans to release its unaudited financial results for the first quarter ended March 31, 2018 on May 15, 2018 before the U.S. market opens.
SHENZHEN, China, April 26, 2018 (GLOBE NEWSWIRE) -- Xunlei Limited ("Xunlei" or the "Company") (Nasdaq:XNET), a leading cloud-based acceleration technology company in China, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2017 with the Securities and Exchange Commission, or the SEC. The annual report can be accessed on the Company’s investor relations website at http://ir.
7h - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
Silicon Investor Message Boards
This table lists all message boards related to XNET / Xunlei Limited on message board site Silicon Investor.
|Xin Net Technologies - BB: XNET - The Next Internet Stock?||IXnet-NASDAQ-(EXNT)|
|MXNT u003eu003e MaxNet Inc. u003eu003e Undiscovered Web Portal u003eu003e MXNT||XNET PARTNERS WITH MICROSOFT AND IBM IN CHINA|
as of ET